Copyright
©The Author(s) 2004.
World J Gastroenterol. Apr 15, 2004; 10(8): 1132-1136
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1132
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1132
Groups | OD values | Survival rate (%) | Inhibitory rate (%) |
I | 0.863 ± 0.172 | 100.00 | 0 |
II | 0.425 ± 0.086b | 49.25b | 50.75b |
IIIa | 0.947 ± 0.142 | 109.73 | -9.73 |
IIIb | 0.894 ± 0.220 | 103.59 | -3.59 |
IIIc | 0.848 ± 0.346 | 98.26 | 1.74 |
IIId | 0.844 ± 0.196 | 97.79 | 2.21 |
IVa | 0.338 ± 0.240b | 39.17b | 60.83b |
IVb | 0.318 ± 0.038b | 36.85b | 63.15b |
IVc | 0.318 ± 0.018b | 36.85b | 63.15b |
IVd | 0.306 ± 0.200b | 35.46b | 64.54b |
-
Citation: Chen JY, Liang DM, Gan P, Zhang Y, Lin J.
In vitro effects of recombinant human growth hormone on growth of human gastric cancer cell line BGC823 cells. World J Gastroenterol 2004; 10(8): 1132-1136 - URL: https://www.wjgnet.com/1007-9327/full/v10/i8/1132.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i8.1132